The complex interplay between cholesterol and prostate malignancy

  • Solomon K
  • Freeman M
  • 34


    Mendeley users who have this article in their library.
  • 39


    Citations of this article.


Research into the role of cholesterol and prostate disease has been ongoing for many years, but our mechanistic and translational understanding is still poor. Recent evidence indicates that cholesterol-lowering drugs reduce the risk of aggressive prostate cancer. This article reviews the literature on the relationship between circulating cholesterol and prostate cancer. The data strongly point to hypercholesterolemia as a risk factor for prostate cancer progression and suggest clinical opportunities for the use of cholesterol-lowering therapies to alter disease course. © 2011 Elsevier Inc.

Author-supplied keywords

  • Castration resistance
  • Cholesterol
  • Prostate cancer
  • Statins
  • Steroidogenesis

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Keith R. Solomon

  • Michael R. Freeman

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free